AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 161 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $27,000 | -25.0% | 750 | 0.0% | 0.00% | – |
| Q4 2019 | $36,000 | +50.0% | 750 | 0.0% | 0.00% | – |
| Q3 2019 | $24,000 | -35.1% | 750 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $37,000 | -97.8% | 750 | -97.0% | 0.00% | -96.0% |
| Q1 2019 | $1,702,000 | +51.3% | 25,232 | +3.4% | 0.02% | +31.6% |
| Q4 2018 | $1,125,000 | -40.2% | 24,393 | 0.0% | 0.02% | -29.6% |
| Q3 2018 | $1,881,000 | -9.0% | 24,393 | -0.7% | 0.03% | -12.9% |
| Q2 2018 | $2,068,000 | -7.1% | 24,557 | -9.7% | 0.03% | -8.8% |
| Q1 2018 | $2,225,000 | +27.3% | 27,205 | -11.0% | 0.03% | +25.9% |
| Q4 2017 | $1,748,000 | -13.7% | 30,567 | +0.7% | 0.03% | -18.2% |
| Q3 2017 | $2,026,000 | +62.3% | 30,356 | +25.1% | 0.03% | +50.0% |
| Q2 2017 | $1,248,000 | -14.9% | 24,256 | -3.4% | 0.02% | -15.4% |
| Q1 2017 | $1,466,000 | +105.6% | 25,098 | +46.8% | 0.03% | +100.0% |
| Q4 2016 | $713,000 | -21.4% | 17,094 | -0.5% | 0.01% | -27.8% |
| Q3 2016 | $907,000 | +26.0% | 17,180 | 0.0% | 0.02% | +20.0% |
| Q2 2016 | $720,000 | +3.2% | 17,180 | 0.0% | 0.02% | 0.0% |
| Q1 2016 | $698,000 | -38.0% | 17,180 | -0.8% | 0.02% | -40.0% |
| Q4 2015 | $1,125,000 | -7.6% | 17,325 | +0.5% | 0.02% | -13.8% |
| Q3 2015 | $1,217,000 | -36.2% | 17,239 | +0.3% | 0.03% | -31.0% |
| Q2 2015 | $1,909,000 | +81.1% | 17,179 | +53.7% | 0.04% | +82.6% |
| Q1 2015 | $1,054,000 | – | 11,179 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 514,711 | $22,194,338 | 5.19% |
| ACUTA CAPITAL PARTNERS, LLC | 78,700 | $3,393,544 | 2.86% |
| Bellevue Group AG | 3,879,548 | $167,286,110 | 2.72% |
| Parkman Healthcare Partners LLC | 446,416 | $19,249,458 | 2.58% |
| Eagle Health Investments LP | 330,830 | $14,265,390 | 2.50% |
| SECTOR GAMMA AS | 121,844 | $5,253,913 | 1.96% |
| Frazier Life Sciences Management, L.P. | 871,974 | $37,599,519 | 1.76% |
| BVF INC/IL | 1,190,107 | $51,317,414 | 1.44% |
| Rock Springs Capital Management LP | 1,044,261 | $45,028,534 | 1.36% |
| FARALLON CAPITAL MANAGEMENT LLC | 5,654,502 | $243,822,126 | 1.15% |